We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+7.07%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.24%
AUM
$17.4B
AUM Growth
+$359M
(+2.1%)
Cap. Flow
-$480M
Cap. Flow
% of AUM
-2.77%
Top 10 Holdings %
Top 10 Hldgs %
19.12%
Holding
357
New
45
Increased
93
Reduced
141
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$141M |
| 2 |
DFS
Discover Financial Services
DFS
|
+$129M |
| 3 |
Biogen
BIIB
|
+$126M |
| 4 |
United Therapeutics
UTHR
|
+$124M |
| 5 |
Whirlpool
WHR
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
+$274M |
| 2 |
ENDP
Endo International plc
ENDP
|
+$207M |
| 3 |
SHPG
Shire pic
SHPG
|
+$206M |
| 4 |
MWIV
MWI VETERINARY SUPPLY, INC.
MWIV
|
+$137M |
| 5 |
JPMorgan Chase
JPM
|
+$132M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.8% |
| 2 | Technology | 14.71% |
| 3 | Consumer Discretionary | 13.45% |
| 4 | Industrials | 12.27% |
| 5 | Communication Services | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JAH
26
DELISTED
JARDEN CORPORATION
JAH
| $145M | 0.84% |
2,742,662
-193,177
| -7% | -$9.75M |
|
27
Citigroup
C
$230B
| $145M | 0.84% |
2,813,077
+391,051
| +16% | +$19.9M |
|
28
PPG Industries
PPG
$25.3B
| $144M | 0.83% |
1,278,960
-29,840
| -2% | -$3.42M |
|
29
Dollar Tree
DLTR
$25.1B
| $143M | 0.83% |
1,765,556
-39,591
| -2% | -$3.01M |
|
30
PTC Therapeutics
PTCT
$5.68B
| $143M | 0.82% |
2,344,341
+1,613,031
| +221% | +$98.4M |
|
31
Starbucks
SBUX
$120B
| $142M | 0.82% |
2,991,922
-57,058
| -2% | -$2.56M |
|
|
32
United Therapeutics
UTHR
$22B
| $140M | 0.81% |
+813,458
| New | +$124M |
|
33
Danaher
DHR
$137B
| $140M | 0.81% |
2,453,850
-48,008
| -2% | -$2.75M |
|
|
34
Mastercard
MA
$500B
| $140M | 0.81% |
+1,619,899
| New | +$141M |
|
35
Palo Alto Networks
PANW
$299B
| $139M | 0.8% |
5,705,316
+124,044
| +2% | +$2.78M |
|
36
VF Corp
VFC
$5.87B
| $138M | 0.79% |
1,941,517
+252,933
| +15% | +$17.5M |
|
|
37
Biogen
BIIB
$30.8B
| $135M | 0.78% |
320,001
+319,311
| +46,277% | +$126M |
|
38
Caterpillar
CAT
$404B
| $135M | 0.78% |
1,684,789
+492,096
| +41% | +$40.9M |
|
39
Qualcomm
QCOM
$171B
| $132M | 0.76% |
1,897,445
+430,646
| +29% | +$30.3M |
|
40
Halliburton
HAL
$27B
| $123M | 0.71% |
2,813,691
+712,166
| +34% | +$29.7M |
|
|
DFS
41
DELISTED
Discover Financial Services
DFS
| $123M | 0.71% |
+2,185,867
| New | +$129M |
|
42
Thermo Fisher Scientific
TMO
$209B
| $122M | 0.7% |
906,853
-17,448
| -2% | -$2.25M |
|
43
Hershey
HSY
$36B
| $120M | 0.69% |
1,188,034
-29,114
| -2% | -$3.04M |
|
|
EMC
44
DELISTED
EMC CORPORATION
EMC
| $119M | 0.69% |
4,671,668
+700,234
| +18% | +$19.3M |
|
45
Costco
COST
$420B
| $116M | 0.67% |
766,459
-469,723
| -38% | -$68.9M |
|
46
PACCAR
PCAR
$69.5B
| $112M | 0.64% |
2,656,747
-46,260
| -2% | -$1.97M |
|
47
Estee Lauder
EL
$31.5B
| $111M | 0.64% |
1,334,949
-32,410
| -2% | -$2.55M |
|
48
Ulta Beauty
ULTA
$23B
| $110M | 0.63% |
729,860
-18,822
| -3% | -$2.61M |
|
49
Textron
TXT
$15.3B
| $108M | 0.62% |
2,435,678
-46,815
| -2% | -$2.04M |
|
50
RH
RH
$3.29B
| $107M | 0.62% |
1,083,036
-58,970
| -5% | -$5.35M |
|
Similar funds
OAG
JG
CHP
SC
Westfield Capital Management's Q1 2015 Portfolio in Review
As of Q1 2015, Westfield Capital Management held 357 positions worth $17.4B, up 2.1% from $17B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Westfield Capital Management's Q1 2015 filing shows 45 new, 93 increased, 141 reduced and 56 closed positions. Its largest new stake was Mastercard: 1,619,899 shares worth $140M. The largest sale was CUBIST PHARMACEUTICALS INC, an estimated $274M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
- Westfield Capital Management's largest Q1 2015 buy was Mastercard: 1,619,899 shares worth $140M.
- Westfield Capital Management added most to Biogen in Q1 2015, an estimated $126M increase.
- Westfield Capital Management's biggest Q1 2015 reduction was Shire pic, cutting an estimated $206M.
- Westfield Capital Management fully exited CUBIST PHARMACEUTICALS INC in Q1 2015, selling an estimated $274M.
- Westfield Capital Management's ten largest holdings make up 19% of its $17.4B portfolio in Q1 2015.
- Westfield Capital Management opened 45 new positions and closed 56 in Q1 2015.
- Westfield Capital Management's portfolio value rose 2.1% quarter-over-quarter to $17.4B.
Based on Westfield Capital Management's 13F filing for Q1 2015, filed 13 May 2015.